Campath-1H humanized monoclonal antibody: ILXO and partner LeukoSite Inc. completed enrollment of 94 patients in a pivotal Phase II trial

Ilex Oncology Inc. (ILXO), San Antonio,

Read the full 62 word article

How to gain access

Continue reading with a
two-week free trial.